Crowdonomics
WatchlistPortfolio
All companies
TTC ONCOLOGY logo

TTC ONCOLOGY

Operating

TTC Oncology, LLC

Software & AI · Founded 2015

Visit website

Developed TTC-352, a small molecule to fight breast cancer

Valuation cap ⓘ
$25.0M
As of Apr 2023 · from Reg CF Offering (2021) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$141,830
Across 1 round since 2021

Financials

FY2019–FY2020 · from SEC filings · hover any figure for its source
$0
−$1.2M
2019
$0
−$100K
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed*
FY2020 reviewed*
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$1,207,239
-$99,617
Taxes paid
$0
$0
Balance sheet
Cash
$87,628
$117,558
Accounts receivable
$0
$0
Total assets
$485,956
$486,339
Short-term debt
$0
$0
Long-term debt
$408,446
$408,446
Total liabilities
$408,446
$408,446
Other
Headcount
—
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$25.0M
Valuation cap
Reg CF · SAFE · Dec 2021

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Reg CF · SAFE · Dec 2021Closedvia WeFunder
Raised $141.8K / $1MInvestors 73Valuation cap $25M

Team

5 people
Arkadiusz Dudek
Chief Executive Officer
Debra A. Tonetti
Chief Scientific Officer
Gregory R J Thatcher
CTO
Laura P Kiernan
Advisor
Melody A Pekarek
Manager

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 5 annual reports (FY2021–FY2025)

Missing: 2021, 2022, 2023, 2024, 2025

73 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C/AApr 12, 20220001670254-22-000321
    EDGAR
  • Form C/AFeb 11, 20220001670254-22-000143
    EDGAR
  • Form CDec 6, 20210001670254-21-001351
    EDGAR
Source: ManualCIK 0001889745

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.